These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3878121)

  • 1. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
    Coleman MS; Danton MJ; Philips A
    Ann N Y Acad Sci; 1985; 451():54-65. PubMed ID: 3878121
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of possible relation of defects in purine metabolism to immune deficiency.
    Seegmiller JE
    Ann N Y Acad Sci; 1985; 451():9-19. PubMed ID: 3935028
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation of mutant adenosine deaminase by coformycin affinity chromatography.
    Danton MJ; Coleman MS
    Anal Biochem; 1986 Nov; 159(1):233-9. PubMed ID: 3492941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H; Thorbecke GJ; Hirschhorn R
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease.
    Dyminski JW; Daoud A; Lampkin BC; Limouze S; Donofrio J; Coleman MS; Hutton JJ
    Clin Immunol Immunopathol; 1979 Nov; 14(3):307-26. PubMed ID: 498598
    [No Abstract]   [Full Text] [Related]  

  • 8. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
    Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ
    Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic basis for immune dysfunction in adenosine deaminase deficiency.
    Carson DA; Iizasa T; Seto S; Carrera CJ; Kubota M; Willis EH; Wasson DB; Kajander O
    Ann N Y Acad Sci; 1985; 451():34-41. PubMed ID: 3878120
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
    Raivio KO; Schwartz AL; Stern RC; Polmar SH
    Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 13. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].
    Souillet G
    Pediatrie; 1975; 30(7):746-56. PubMed ID: 1105387
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenosine deaminase and immunodeficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):124-7. PubMed ID: 1148377
    [No Abstract]   [Full Text] [Related]  

  • 16. Levels of adenosine deaminase AMP deaminase, and adenylate kinase in cultured human lymphoblast lines: exquisite sensitivity of AMP deaminase to adenosine deaminase inhibitors.
    Fishbein WN; Davis JI; Winkert JW; Strong DM
    Biochem Med; 1981 Dec; 26(3):377-86. PubMed ID: 6277304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
    Polmar SH
    Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.